CN111543572A - 固体饮料及其制备方法 - Google Patents
固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN111543572A CN111543572A CN201910109686.0A CN201910109686A CN111543572A CN 111543572 A CN111543572 A CN 111543572A CN 201910109686 A CN201910109686 A CN 201910109686A CN 111543572 A CN111543572 A CN 111543572A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- compound
- solid beverage
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 35
- 239000007787 solid Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title description 5
- 239000000284 extract Substances 0.000 claims abstract description 71
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 38
- 239000011707 mineral Substances 0.000 claims abstract description 38
- 229940088594 vitamin Drugs 0.000 claims abstract description 38
- 229930003231 vitamin Natural products 0.000 claims abstract description 38
- 235000013343 vitamin Nutrition 0.000 claims abstract description 38
- 239000011782 vitamin Substances 0.000 claims abstract description 38
- -1 compound amino acid Chemical class 0.000 claims abstract description 36
- 150000001875 compounds Chemical class 0.000 claims abstract description 35
- 241000219422 Urtica Species 0.000 claims abstract description 33
- 235000020708 ginger extract Nutrition 0.000 claims abstract description 33
- 229940002508 ginger extract Drugs 0.000 claims abstract description 33
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 32
- 239000010018 saw palmetto extract Substances 0.000 claims abstract description 28
- 229940063845 saw palmetto extract Drugs 0.000 claims abstract description 28
- 235000013305 food Nutrition 0.000 claims abstract description 21
- 239000000126 substance Substances 0.000 claims abstract description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 75
- 235000010755 mineral Nutrition 0.000 claims description 37
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 36
- 229940024606 amino acid Drugs 0.000 claims description 36
- 239000002131 composite material Substances 0.000 claims description 27
- 235000021552 granulated sugar Nutrition 0.000 claims description 27
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 25
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 25
- 229940073490 sodium glutamate Drugs 0.000 claims description 25
- 239000002994 raw material Substances 0.000 claims description 19
- 229920002774 Maltodextrin Polymers 0.000 claims description 18
- 239000005913 Maltodextrin Substances 0.000 claims description 18
- 229940035034 maltodextrin Drugs 0.000 claims description 18
- 239000000377 silicon dioxide Substances 0.000 claims description 18
- 235000012239 silicon dioxide Nutrition 0.000 claims description 18
- 235000009108 Urtica dioica Nutrition 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 15
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 229920002261 Corn starch Polymers 0.000 claims description 8
- 229920000881 Modified starch Polymers 0.000 claims description 8
- 239000008120 corn starch Substances 0.000 claims description 8
- 235000015165 citric acid Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000004806 packaging method and process Methods 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 241000288110 Fulica Species 0.000 claims description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 3
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 3
- 239000002211 L-ascorbic acid Substances 0.000 claims description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 239000004227 calcium gluconate Substances 0.000 claims description 3
- 229960004494 calcium gluconate Drugs 0.000 claims description 3
- 235000013927 calcium gluconate Nutrition 0.000 claims description 3
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 3
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 3
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 3
- 235000020755 serenoa repens extract Nutrition 0.000 claims description 3
- 239000011647 vitamin D3 Substances 0.000 claims description 3
- 235000005282 vitamin D3 Nutrition 0.000 claims description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 3
- 229940021056 vitamin d3 Drugs 0.000 claims description 3
- 239000011670 zinc gluconate Substances 0.000 claims description 3
- 235000011478 zinc gluconate Nutrition 0.000 claims description 3
- 229960000306 zinc gluconate Drugs 0.000 claims description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims 2
- 235000006008 Brassica napus var napus Nutrition 0.000 claims 2
- 240000000385 Brassica napus var. napus Species 0.000 claims 2
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims 2
- 230000003779 hair growth Effects 0.000 abstract description 19
- 210000004761 scalp Anatomy 0.000 abstract description 9
- 230000031774 hair cycle Effects 0.000 abstract description 2
- 210000004209 hair Anatomy 0.000 description 27
- 201000004384 Alopecia Diseases 0.000 description 22
- 231100000360 alopecia Toxicity 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 210000003780 hair follicle Anatomy 0.000 description 12
- 230000033001 locomotion Effects 0.000 description 11
- 239000008280 blood Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 235000013376 functional food Nutrition 0.000 description 8
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 208000004631 alopecia areata Diseases 0.000 description 6
- 230000003676 hair loss Effects 0.000 description 6
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 5
- 239000003098 androgen Substances 0.000 description 5
- 229960003473 androstanolone Drugs 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 208000024963 hair loss Diseases 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002021 butanolic extract Substances 0.000 description 2
- 230000003778 catagen phase Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000011706 ferric diphosphate Substances 0.000 description 2
- 235000007144 ferric diphosphate Nutrition 0.000 description 2
- 229940036404 ferric pyrophosphate Drugs 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 102100032187 Androgen receptor Human genes 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 208000030695 Sparse hair Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 241000234314 Zingiber Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 108010080146 androgen receptors Proteins 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000034557 congenital alopecia Diseases 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000034653 disorder of pilosebaceous unit Diseases 0.000 description 1
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 1
- 208000024349 endocrine alopecia Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008949 local secretion Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 102000009310 vitamin D receptors Human genes 0.000 description 1
- 108050000156 vitamin D receptors Proteins 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明提供一种食品组合物及其包含该食品组合物的固体饮料，以油菜花提取物、生姜提取物、宽叶荨麻提取物、锯棕榈提取物、人参提取物、复合氨基酸粉、复合矿物质和复合维生素为主要组分。本发明提供的食品组合物及其包含该食品组合物的固体饮料，可改善头皮环境，调节头发生长周期，可有效促进头发生长。
Description
技术领域
本发明属于功能食品技术领域，具体涉及一种促进头发生长的固体饮料及其制备方法。
背景技术
脱发是皮肤科中的常见病、多发病，包括脂溢性脱发、斑秃、早秃等。正常脱落的头发都是处于退行期及休止期的毛发，由于进入退行期与新进入生长期的毛发不断处于动态平衡，故能维持正常数量的头发。病理性脱发是指头发异常或过度的脱落。
脱发的原因多种多样，有神经性脱发、先天性脱发、季节性脱发以及内分泌脱发等，但是最为常见的是雄激素性脱发，占所有脱发类型的95%左右。在雄激素的作用下，具有遗传易感性的人群，受油脂局部分泌的影响，头顶部的毛囊逐渐萎缩，毛囊体积缩小，终毛毛囊转变为毳毛毛囊，直至消失，从而使头发变细脱落。萎缩的毛囊无法长出新头发，头发数量越来越少。女性秃发者比男性秃发者要少得多，就是因为女性体内的雄性激素分泌量很少。
现代药理研究发现，斑秃是一种与自身免疫有关的毛发疾病，具有遗传易感性的人更容易脱发，其遗传特性需在雄性激素作用下才能表现出来。睾酮是男性的主要雄激素，经5α还原酶（I型、II型）转化为二氢睾酮（DHT），它结合雄激素受体的能力比睾酮强5 倍以上。而且，二氢睾酮前者会导致毛囊萎缩，最终导致秃顶。因此，AGA 患者毛囊中的5α还原酶活性异常增高。是其脱发的主要原因，抑制5α还原酶活性。同时调节激素的分泌量是治疗的主要机理依据。
中医理论认为，“发为血之余，发为肾之主”，头发稀疏或干枯不荣多为精血、肝肾不足之证。斑秃又称“油风、鬼剃头”，中医学者认为，斑秃是因肝肾虚亏、精血不足，不能随气上营皮肤，以致腠理不固，毛孔张开，风邪乘虚而入，风盛血燥，发失所养，发枯而脱，此外，情志不遂、气血失调也与本病发生有密切关系。因此，中医调理方面主要针对血瘀毛窍型，治以活血化瘀、疏通经络为主，常用活血通络药物。
目前，市面上防止脱发促进生发的产品众多，但大多为西药类药物，治疗的同时具有一定的副作用，且易产生耐药性，故不宜长期服用。但防脱生发的治疗需要相对较长的疗程，所以中草药以其药性缓和、不易产生耐药性、适合长期服用的特点，更适合于防脱生发的治疗。本发明以药性相对缓和的具有促进生发作用的中药材为原料，同时配伍维生素和矿物质，通过改善头皮微循环，调整体内雄激素水平，给头发提供必须的营养物质，从而确保了防脱促生发的疗效。同时本产品采用传统的混合、制粒工艺，生产可行性相对较高。
发明内容
本发明的目的在于，针对现有技术存在的问题，提供了一种食品组合物及包含该食品组合物的固体饮料，从促进血液循环角度，为头发生长提供营养支持，以实现促进头发生长的功能。
另一个目的，本发明还提供了所述固体饮料的制备方法。
本发明的目的是通过以下技术方案来实现的：本发明提供一种食品组合物，包括以下组分：油菜花提取物、生姜提取物、宽叶荨麻提取物、锯棕榈提取物、人参提取物、复合氨基酸粉、复合矿物质和复合维生素。
进一步地，按照重量份数计算，所述食品组合物包括油菜花提取物5-20份、生姜提取物1-10份、宽叶荨麻提取物0.5-5份、锯棕榈提取物0.3-5份、人参提取物0.1-3份、复合氨基酸粉1-10份、复合矿物质0.5-10份和复合维生素0.05-5份。
优选地，按照重量份数计算，所述食品组合物包括油菜花提取物8-12份，生姜提取物3-8份、宽叶荨麻提取物0.5-3份、锯棕榈提取物0.5-3份、人参提取物0.2-3份、复合氨基酸粉3-6份、复合矿物质1-5份和复合维生素0.1-3份。
另一方面，本发明提供一种固体饮料，包括以下组分：油菜花提取物、生姜提取物、宽叶荨麻提取物、锯棕榈提取物、人参提取物、复合氨基酸粉、复合矿物质、复合维生素、调味剂和载体。
进一步地，，所述调味剂选自白砂糖、柠檬酸或谷氨酸钠中的一种或多种。
进一步地，所述载体选自麦芽糊精、玉米淀粉、预胶化淀粉、二氧化硅中的一种或多种。
进一步地，按照重量份数计算，所述固体饮料包括油菜花提取物5-20份、生姜提取物1-10份、宽叶荨麻提取物0.5-5份、锯棕榈提取物0.3-5份、人参提取物0.1-3份、复合氨基酸粉1-10份、复合矿物质0.5-10份、复合维生素0.05-5份、白砂糖50～95份、柠檬酸0.005～0.03份、谷氨酸钠0.005～0.03份、麦芽糊精0.5～2份、玉米淀粉0.2-1份、预胶化淀粉0.2-1份和二氧化硅0.8～1.5%份。
进一步地，按照重量份数计算，所述固体饮料包括油菜花提取物8-12份，生姜提取物3-8份、宽叶荨麻提取物0.5-3份、锯棕榈提取物0.5-3份、人参提取物0.2-3份、复合氨基酸粉3-6份、复合矿物质1-5份、复合维生素0.1-3份、白砂糖50～60份、柠檬酸0.01～0.02份、谷氨酸钠0.01～0.02份、麦芽糊精0.5～1份、玉米淀粉0.5-1份、预胶化淀粉0.5-1份和二氧化硅1～1.5份。
进一步地，所述复合矿物质包含葡萄糖酸钙、焦磷酸铁和葡萄糖酸锌；所述复合维生素包含胆钙化醇、dl-α-醋酸生育酚、盐酸吡哆醇和L-抗坏血酸。
另一方面，本发明提供上述固体饮料的制备方法，包含以下步骤：
（1）原料准备：将白砂糖、柠檬酸、谷氨酸钠、分别粉碎过80目筛，备用；
（2）原料混合：按照配比将油菜花提取物5-20份、生姜提取物1-10份、宽叶荨麻提取物0.5-5份、锯棕榈提取物0.3-5份、人参提取物0.1-3份、复合氨基酸粉1-10份、复合矿物质0.5-10份、复合维生素0.05-5份、麦芽糊精0.5～2份、玉米淀粉0.2-1份、预胶化淀粉0.2-1份、二氧化硅0.8～1.5份、柠檬酸0.005～0.03份、谷氨酸钠0.005～0.03份加入混合机进行预混；再将白砂糖50～95份加入混合机混合至均匀；
（3）采用全自动定量包装机进行定量分装，每袋10g。
本发明为功能食品允许范围内中草药的提取物，均可以从市面购得。其中，
油菜花粉提取物：油菜花粉的乙醇提取物经硅胶柱层析分离得到一种黄色的、油状多聚醚成分，对5α还原酶有抑制作用。花粉中的VE、超氧化歧化酶(SOD)、硒等成分能滋润营养肌肤，恢复皮肤的弹性和光洁。花粉中的肌醇可使白发变黑，脱发渐生，保持头发乌黑亮丽。其机理在于全面调节人体内分泌系统的平衡，由里及表，从根本上改善皮肤细胞的活力，增强皮肤的代谢机能，防止面部色素沉着、皮肤粗糙、衰老，使皮肤保持湿润、洁白，有光泽，富有弹性。
生姜提取物：生姜中姜辣素、姜烯油等成分，具有刺激头皮，加快气血运动的作用，可加速皮肤血液循环，促进头皮新陈代谢，活化毛囊组织，有效地防止脱发。
锯棕榈提取物：锯棕榈提取物富含脂肪(月桂酸，油酸，豆蔻酸，棕榈酸)，多糖和植物固醇。它通过阻止雄性激素和阻止DHT对毛囊的破坏来实现治疗脱发的，此外可促使毛囊恢复，改善发质，减少头皮对刺激和压力的敏感度。
宽叶荨麻提取物：宽叶荨麻水提物的正丁醇萃取物对5α还原酶有明显的抑制作用，其效果与阳性对照药非那雄胺接近；5α还原酶抑制剂，可通过抑制血清中的睾酮转化为二氢睾酮，降低体内二氢睾酮的水平，从而抑制了二氢睾酮对毛囊的破坏作用起到生发作用。
人参提取物：人参提取物中的人参皂甙可部分影响凝血酶活性而抑制血小板的聚集作用，促进血液循环。同时能扩张皮下毛细血管，提高皮肤温度，改善微循环。
复合氨基酸粉：氨基酸是人体生命运动中所必须的基本物质，其生理作用是促进蛋白质合成如角蛋白、生长激素分泌，提高机体的免疫能力。头发的基本成份是角质蛋白，约占头发全部成分的90%以上，主要为角化的角质细胞形成，角质细胞内充满多种氨基酸组成的角蛋白，它们提供头发生长所需的营养与成份，其中以胱氨酸的含量最高；而这种氨基酸人体并不能合成，必须由摄入的蛋白质来提供。因此外界摄入适量的复合氨基酸，才能提供头发生长所需的营养物质，才能保证头发的正常生长。
复合维生素：复合维生素由维生素B6、维生素C、维生素D、维生素E组成，其中维生素B6可进入人体参与辅酶代谢，通过血液循环作用于头皮，对调节脂肪及脂肪酸的合成，抑制皮脂分泌，刺激毛发再生有重要作用；维生素C可调节皮脂腺分泌；活化微血管壁，使发根能够顺利吸收血液中的营养。维生素D可通过毛囊中的维生素D受体来激活毛囊，使得它重新开放，头发恢复正常的生长周期；维生素E可抗衰老作用，改善头发毛囊的微循环。
复合矿物质：复合矿物质由钙铁锌元素组成，其中钙对心脏、神经、肌肉、皮肤、毛发、骨骼和牙齿的健康极为重要。灰白发一般是由于钙含量偏低；铁可运输氧和血红蛋白，铁缺乏可引起斑秃及大面积脱发；锌对头发颜色起作用，通过活化酶发挥作用，合成各种酶；缺乏，引起头发脱落，出现头屑。
本发明提供的促进头发生长的功能食品组合物，其配方以中药为主要成分，同时添加复合维生素和矿物质，从补充头发所需营养角度考虑，结合现代药理研究，科学配伍，能有效促进头发生长。
通过向本发明所述的功能食品组合物中加入载体和调味剂，制成适于服用的固体饮料，便于携带，服用方便。
本发明提供的功能食品组合物及固体饮料，经过人体体内功效验证，表明具有显著的促进头发生长的功能。
本发明提供的促进头发生长的功能食品，其方中精选各药为国家规定的原料目录中所选，用量上严格限制在一定范围，所以安全有效，无毒副作用，可长期食用。
本发明提供的促进头发生长的功能食品，其可改善头皮环境，调节头发生长周期，促进头发生长的功能。
具体实施例
下面结合具体的实施例对本发明做进一步的详细说明，但本发明的实施方式不限于此。
应当理解，本文所使用的诸如“具有”、“包含”以及“包括”术语并不排除一个或多个其它组合的存在或添加。
实施例1
本实施例提供一种食品组合物，按照重量份数计算，包含油菜花提取物8份、生姜提取物2份、宽叶荨麻提取物1份、锯棕榈提取物1份、人参提取物0.2份、复合氨基酸粉2份、复合矿物质1份、复合维生素0.5份。
进一步地，本实施例还提供一种固体饮料，按照重量份数计算，包含油菜花提取物8份、生姜提取物2份、宽叶荨麻提取物1份、锯棕榈提取物1份、人参提取物0.2份、复合氨基酸粉2份、复合矿物质1份、复合维生素0.5份、麦芽糊精1份、二氧化硅1份、柠檬酸0.01份、谷氨酸钠0.008份和白砂糖70份。
另一方面，本实施例提供上述固体饮料的制备方法，包括以下步骤：
（1）原料准备：取白砂糖、柠檬酸、谷氨酸钠，分别粉碎过80目筛，备用；
（2）原料混合：按照配比将油菜花提取物8份、生姜提取物2份、宽叶荨麻提取物1份、锯棕榈提取物1份、人参提取物0.2份、复合氨基酸粉2份、复合矿物质1份、复合维生素0.5份、麦芽糊精1份、二氧化硅1份、柠檬酸0.01份和谷氨酸钠0.008份加入三维运动混合机（SYH-15）进行预混10分钟；再将白砂糖70份加入三维运动混合机（SYH-15）与预混料再次进行混合至均匀；
（3）采用全自动定量包装机（DXDF-300背封）进行定量分装，每袋10g。
以上步骤均在洁净区完成。
实施例2
本实施例提供一种食品组合物，按照重量份数计算，包含油菜花提取物6份、生姜提取物3份、宽叶荨麻提取物2份、锯棕榈提取物3份、人参提取物0.5份、复合氨基酸粉7份、复合矿物质4份、复合维生素0.6份。
进一步地，本实施例还提供一种固体饮料，按照重量份数计算，包含油菜花提取物6份、生姜提取物3份、宽叶荨麻提取物2份、锯棕榈提取物3份、人参提取物0.5份、复合氨基酸粉7份、复合矿物质4份、复合维生素0.6份、麦芽糊精0.8份、二氧化硅1.2份、柠檬酸0.02份、谷氨酸钠0.02份和白砂糖65份。
另一方面，本实施例提供上述固体饮料的制备方法，包括以下步骤：
（1）原料准备：取白砂糖、柠檬酸、谷氨酸钠，分别粉碎过80目筛，备用；
（2）原料混合：按照配比将油菜花提取物6份、生姜提取物3份、宽叶荨麻提取物2份、锯棕榈提取物3份、人参提取物0.5份、复合氨基酸粉7份、复合矿物质4份、复合维生素0.6份、麦芽糊精0.8份、二氧化硅1.2份、柠檬酸0.02份、谷氨酸钠0.02份加入三维运动混合机（SYH-15）进行预混10分钟；再按配比将白砂糖65份加入三维运动混合机（SYH-15）进行混合至均匀；
（3）采用全自动定量包装机（DXDF-300背封）进行定量分装，每袋10g。
实施例3
本实施例提供一种食品组合物，按照重量份数计算，包含油菜花提取物10份、生姜提取物5份、宽叶荨麻提取物1.6份、锯棕榈提取物1.5份、人参提取物0.3份、复合氨基酸粉5份、复合矿物质3.5份、复合维生素0.3份。
进一步地，本实施例还提供一种固体饮料，按照重量份数计算，包含油菜花提取物10份、生姜提取物5份、宽叶荨麻提取物1.6份、锯棕榈提取物1.5份、人参提取物0.3份、复合氨基酸粉5份、复合矿物质3.5份、复合维生素0.3份、麦芽糊精0.78份、二氧化硅1份、柠檬酸0.01份、谷氨酸钠0.01份和白砂糖70份。
另一方面，本实施例提供上述固体饮料的制备方法，包括以下步骤：
（1）原料准备：取白砂糖、柠檬酸、谷氨酸钠，分别粉碎过80目筛，备用；
（2）原料混合：将油菜花提取物10份、生姜提取物5份、宽叶荨麻提取物1.6份、锯棕榈提取物1.5份、人参提取物0.3份、复合氨基酸粉5份、复合矿物质3.5份、复合维生素0.3份、麦芽糊精0.78份、二氧化硅1份、柠檬酸0.01份、谷氨酸钠0.01份加入三维运动混合机（SYH-15）进行预混10分钟；再按配比将白砂糖70份加入三维运动混合机（SYH-15）与预混料再次进行混合均匀；
（3）采用全自动定量包装机（DXDF-300背封）进行定量分装，每袋10g。
实施例4
本实施例提供一种食品组合物，按照重量份数计算，包含油菜花提取物15份、生姜提取物7份、宽叶荨麻提取物3份、锯棕榈提取物2份、人参提取物2份、复合氨基酸粉2份、复合矿物质6份、复合维生素2份。
进一步地，本实施例还提供一种固体饮料，按照重量份数计算，包含油菜花提取物15份、生姜提取物7份、宽叶荨麻提取物3份、锯棕榈提取物2份、人参提取物2份、复合氨基酸粉2份、复合矿物质6份、复合维生素2份、麦芽糊精1.5份、二氧化硅1.3份、柠檬酸0.02份、谷氨酸钠0.01份、白砂糖80份。
另一方面，本实施例提供上述固体饮料的制备方法，包括以下步骤：
（1）原料准备：取白砂糖、柠檬酸、谷氨酸钠，分别粉碎过80目筛，备用；
（2）原料混合：将油菜花提取物15份，生姜提取物7份、宽叶荨麻提取物3份、锯棕榈提取物2份，人参提取物2份，复合氨基酸粉2份，复合矿物质6份，复合维生素2份，麦芽糊精1.5份，二氧化硅1.3份，柠檬酸0.02份，谷氨酸钠0.01份加入三维运动混合机（SYH-15）进行预混10分钟；再按配比将白砂糖80份加入三维运动混合机（SYH-15）与预混料再次进行混合至均匀；
（3）采用全自动定量包装机（DXDF-300背封）进行定量分装，每袋10g。
实施例5
本实施例提供一种食品组合物，按照重量份数计算，包含油菜花提取物13份、生姜提取物7份、宽叶荨麻提取物3.2份、锯棕榈提取物2.8份、人参提取物1.5份、复合氨基酸粉6.5份、复合矿物质5份、复合维生素1份。
进一步地，本实施例还提供一种固体饮料，按照重量份数计算，包含油菜花提取物13份、生姜提取物7份、宽叶荨麻提取物3.2份、锯棕榈提取物2.8份、人参提取物1.5份、复合氨基酸粉6.5份、复合矿物质5份、复合维生素1份、麦芽糊精0.85份、二氧化硅0.9份、柠檬酸0.02份、谷氨酸钠0.008份和白砂糖75份。
（1）原料准备：阿胶、白砂糖、柠檬酸、谷氨酸钠、分别粉碎过80目筛，备用；
（2）原料混合：按照配比油菜花提取物13份，生姜提取物7份、宽叶荨麻提取物3.2份、锯棕榈提取物2.8份，人参提取物1.5份，复合氨基酸粉6.5份，复合矿物质（葡萄糖酸钙，焦磷酸铁，葡萄糖酸锌）5份，复合维生素（胆钙化醇，dl-α-醋酸生育酚，盐酸吡哆醇、L-抗坏血酸）1份，麦芽糊精0.85份，二氧化硅0.9份，柠檬酸0.02份，谷氨酸钠0.008份的50倍量先采用三维运动混合机（SYH-15）进行预混（约10分钟）；再按配比白砂糖75份的50倍量加入三维运动混合机（SYH-15）与预混料再次进行混合（约20分钟）至均匀；
（3）采用全自动定量包装机（DXDF-300背封）进行定量分装，每袋10g。
本发明克服了现有技术的不足，提供了一种促进头发生长的食品组合物及包含该食品组合物的固体饮料。以油菜花提取物、生姜提取物、宽叶荨麻提取物、锯棕榈提取物、人参提取物、复合维生素、复合矿物质、复合氨基酸粉为主料，其中油菜花提取物、生姜提取物、宽叶荨麻提取物、锯棕榈提取物、人参提取物通过直接采购原料，保证有效成分的含量；复合维生素，复合矿物质，复合氨基酸粉直接采购复配营养素，保证其含量，从而确保产品功能。
本产品配方以中医基础理论为指导，同时结合现代药理研究，进行复合配比，确保产品的功效。加入白砂糖等辅料，制成适于服用的固体饮料，相比原药材，提高产品的生物利用度，且便于携带和运输。另外，经人体试验证明，具有促进头发生长的功能。同时，方中精选各药为国家允许的药食同源及保健食品原料，用量上严格限制在一定范围，所以安全有效，服用无毒副作用，可长期食用，其可调节头皮功能，促进头发生长。
尽管本发明的实施方案已公开如上，但其并不仅仅限于说明书和实施方式中所列运用，全可以被适用于各种适合本发明的领域，对于熟悉本领域的人员而言，可容易地实现另外的修改，因此在不背离权利要求及等同范围所限定的一般概念下，本发明并不限于特定的细节和这里示出与描述的实施例。
Claims (10)
1.食品组合物，其特征在于，包括以下组分：油菜花提取物、生姜提取物、宽叶荨麻提取物、锯棕榈提取物、人参提取物、复合氨基酸粉、复合矿物质和复合维生素。
2.根据权利要求1所述的食品组合物，其特征在于，按照重量份数计算，所述食品组合物包括油菜花提取物5-20份、生姜提取物1-10份、宽叶荨麻提取物0.5-5份、锯棕榈提取物0.3-5份、人参提取物0.1-3份、复合氨基酸粉1-10份、复合矿物质0.5-10份和复合维生素0.05-5份。
3.根据权利要求1所述的食品组合物，其特征在于，按照重量份数计算，所述食品组合物包括油菜花提取物8-12份，生姜提取物3-8份、宽叶荨麻提取物0.5-3份、锯棕榈提取物0.5-3份、人参提取物0.2-3份、复合氨基酸粉3-6份、复合矿物质1-5份和复合维生素0.1-3份。
4.固体饮料，其特征在于，包括以下组分：油菜花提取物、生姜提取物、宽叶荨麻提取物、锯棕榈提取物、人参提取物、复合氨基酸粉、复合矿物质、复合维生素、调味剂和载体。
5.根据权利要求4所述的固体饮料，其特征在于，所述调味剂选自白砂糖、柠檬酸或谷氨酸钠中的一种或多种。
6.根据权利要求4所述的固体饮料，其特征在于，所述载体选自麦芽糊精、玉米淀粉、预胶化淀粉、二氧化硅中的一种或多种。
7.根据权利要求4所述的固体饮料，其特征在于，按照重量份数计算，所述固体饮料包括油菜花提取物5-20份、生姜提取物1-10份、宽叶荨麻提取物0.5-5份、锯棕榈提取物0.3-5份、人参提取物0.1-3份、复合氨基酸粉1-10份、复合矿物质0.5-10份、复合维生素0.05-5份、白砂糖50～95份、柠檬酸0.005～0.03份、谷氨酸钠0.005～0.03份、麦芽糊精0.5～2份、玉米淀粉0.2-1份、预胶化淀粉0.2-1份和二氧化硅0.8～1.5%份。
8.根据权利要求4所述的固体饮料，其特征在于，按照重量份数计算，所述固体饮料包括油菜花提取物8-12份，生姜提取物3-8份、宽叶荨麻提取物0.5-3份、锯棕榈提取物0.5-3份、人参提取物0.2-3份、复合氨基酸粉3-6份、复合矿物质1-5份、复合维生素0.1-3份、白砂糖50～60份、柠檬酸0.01～0.02份、谷氨酸钠0.01～0.02份、麦芽糊精0.5～1份、玉米淀粉0.5-1份、预胶化淀粉0.5-1份和二氧化硅1～1.5份。
9.根据权利要求4所述的固体饮料，其特征在于，，所述复合矿物质包含葡萄糖酸钙、焦磷酸铁和葡萄糖酸锌；所述复合维生素包含胆钙化醇、dl-α-醋酸生育酚、盐酸吡哆醇和L-抗坏血酸。
10.一种固体饮料的制备方法，其特征在于，包含以下步骤：
（1）原料准备：将白砂糖、柠檬酸、谷氨酸钠、分别粉碎过80目筛，备用；
（2）原料混合：按照配比将油菜花提取物5-20份、生姜提取物1-10份、宽叶荨麻提取物0.5-5份、锯棕榈提取物0.3-5份、人参提取物0.1-3份、复合氨基酸粉1-10份、复合矿物质0.5-10份、复合维生素0.05-5份、麦芽糊精0.5～2份、玉米淀粉0.2-1份、预胶化淀粉0.2-1份、二氧化硅0.8～1.5份、柠檬酸0.005～0.03份、谷氨酸钠0.005～0.03份加入混合机进行预混；再将白砂糖50～95份加入混合机混合至均匀；
（3）采用全自动定量包装机进行定量分装，每袋10g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910109686.0A CN111543572A (zh) | 2019-02-11 | 2019-02-11 | 固体饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910109686.0A CN111543572A (zh) | 2019-02-11 | 2019-02-11 | 固体饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111543572A true CN111543572A (zh) | 2020-08-18 |
Family
ID=72007172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910109686.0A Pending CN111543572A (zh) | 2019-02-11 | 2019-02-11 | 固体饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111543572A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110279116A (zh) * | 2019-07-31 | 2019-09-27 | 东莞自然衡健康科技有限公司 | 生发组合物 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1544038A (zh) * | 2003-11-17 | 2004-11-10 | 刘贤英 | 一种黑发生发保健药物及制备工艺 |
| CN106729002A (zh) * | 2016-07-03 | 2017-05-31 | 佛山瑞箭体育器材有限公司 | 一种生发颗粒及其制备方法 |
| CN107028189A (zh) * | 2017-05-03 | 2017-08-11 | 广州正广生物科技有限公司 | 一种具有改善脱发功效的食品组合物 |
| CN107334894A (zh) * | 2016-12-14 | 2017-11-10 | 北京福纳康生物技术有限公司 | 一种治疗脂溢性脱发的组合物 |
| CN107581441A (zh) * | 2017-09-29 | 2018-01-16 | 唐山十三肽保生物工程技术有限公司 | 一种黑芝麻小分子肽复配的固体饮料及其制备方法 |
-
2019
- 2019-02-11 CN CN201910109686.0A patent/CN111543572A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1544038A (zh) * | 2003-11-17 | 2004-11-10 | 刘贤英 | 一种黑发生发保健药物及制备工艺 |
| CN106729002A (zh) * | 2016-07-03 | 2017-05-31 | 佛山瑞箭体育器材有限公司 | 一种生发颗粒及其制备方法 |
| CN107334894A (zh) * | 2016-12-14 | 2017-11-10 | 北京福纳康生物技术有限公司 | 一种治疗脂溢性脱发的组合物 |
| CN107028189A (zh) * | 2017-05-03 | 2017-08-11 | 广州正广生物科技有限公司 | 一种具有改善脱发功效的食品组合物 |
| CN107581441A (zh) * | 2017-09-29 | 2018-01-16 | 唐山十三肽保生物工程技术有限公司 | 一种黑芝麻小分子肽复配的固体饮料及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 唐青涛: "中草药来源的5α-还原酶抑制剂的研究进展", 《华西药学杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110279116A (zh) * | 2019-07-31 | 2019-09-27 | 东莞自然衡健康科技有限公司 | 生发组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2481389B1 (en) | Formulations and treatments for trichology | |
| CN106852937B (zh) | 促进生发、预防脱发和改善毛囊用食用蟋蟀组合物 | |
| CA2634953C (en) | Formulations and treatments for well-being | |
| KR102311987B1 (ko) | 탈모 방지 및 모발 생장 촉진용 화장료 조성물 | |
| KR20140107784A (ko) | 탈모 방지 및 모발 성장 촉진용 조성물 | |
| KR20120069407A (ko) | 탈모를 방지하는 조성물 및 그의 제조방법 | |
| KR101965595B1 (ko) | 탈모 방지 또는 육모 촉진용 조성물 | |
| CN111543572A (zh) | 固体饮料及其制备方法 | |
| KR101965594B1 (ko) | 콩 추출물을 포함하는 탈모 방지 또는 육모 촉진용 조성물 | |
| CN108135820A (zh) | 含有大豆皂苷的生长毛发和/或修复毛发促进用组合物 | |
| CN107028189B (zh) | 一种具有改善脱发功效的食品组合物 | |
| CN111713623A (zh) | 一种固体饮料及其制备方法 | |
| CN107028182A (zh) | 一种抗衰老组合物及制备方法 | |
| EP1900356A1 (de) | Bockshornkleesamenextrakt | |
| CN101411489A (zh) | 藏羊胎素延更养颜复方胶囊 | |
| KR20090038222A (ko) | 발모제 조성물 및 그 제조방법 | |
| US20200085896A1 (en) | Combination of aqueous extracts of watercress and nasturtium and atp for use in the treatment of alopecia | |
| KR102488287B1 (ko) | 비오틴을 포함하는 건강식품 조성물 | |
| AU2012201810B2 (en) | Formulations and treatments for trichology | |
| CN110279116A (zh) | 生发组合物 | |
| KR20100111640A (ko) | 모발생장 촉진 또는 탈모방지용 화장료 조성물의 제조방법 | |
| KR20240139634A (ko) | 탈모 방지 및 발모 촉진용 조성물 | |
| WO2022175991A1 (en) | Food supplement for a nutri-cosmetic treatment of alopecia and for cardiovascular prevention | |
| JPS58162511A (ja) | 養毛用組成物 | |
| KR20230047623A (ko) | 경피흡수율이 우수한 탈모 방지 및 모발 성장 촉진용 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 710042 room 112, floor 1, building A2, standard workshop community, Xi'an Textile Industrial Park, Baqiao District, Xi'an City, Shaanxi Province Applicant after: Shaanxi bairuiheng Health Technology Co.,Ltd. Address before: 523808 room 10, 1st floor, building 1, Dongguan Taiwan Biotechnology cooperation center, No.1 Taoyuan Road, Taiwan hi tech park, Songshanhu hi tech Industrial Development Zone, Dongguan City, Guangdong Province Applicant before: DONGGUAN NATURAL SALUTEM HEALTH TECHNOLOGY CO.,LTD. |
|
| CB02 | Change of applicant information | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200818 |
|
| WD01 | Invention patent application deemed withdrawn after publication |